Cape Investment Advisory’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$546K Sell
8,111
-810
-9% -$54K 0.15% 120
2026
Q1
$560K Sell
8,921
-61
-0.7% -$4.25K 0.19% 108
2025
Q4
$596K Buy
+8,982
New +$581K 0.18% 97
2025
Q3
Sell
-1
Closed -$87 931
2025
Q2
$87 Hold
1
﹤0.01% 1154
2025
Q1
$68 Hold
1
﹤0.01% 1113
2024
Q4
$78 Sell
1
-149
-99% -$11K ﹤0.01% 1115
2024
Q3
$10.1K Buy
+150
New +$12.3K ﹤0.01% 562
2023
Q2
Sell
-8
Closed -$929 932
2023
Q1
$929 Buy
+8
New +$896 ﹤0.01% 877

Other funds holding DXCM

Cape Investment Advisory's DXCM Position: Q2 2026 in Review

Cape Investment Advisory reduced its DexCom (DXCM) stake by 9.1% in Q2 2026, selling an estimated $54K and leaving 8,111 shares worth $546K. The position accounts for 0.15% of the portfolio, ranked #120.

Cape Investment Advisory first reported a position in DXCM in Q1 2023 and has held it in 8 quarters since. The position peaked at $596K in Q4 2025. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Cape Investment Advisory held 8,111 shares of DexCom worth $546K as of Q2 2026.
  • Cape Investment Advisory sold 810 DexCom shares in Q2 2026, an estimated $54K.
  • DexCom made up 0.15% of Cape Investment Advisory's portfolio in Q2 2026, its #120 holding.
  • Cape Investment Advisory first reported a position in DexCom in Q1 2023 and has held it in 8 quarters since.
  • Cape Investment Advisory's DexCom position peaked at $596K in Q4 2025.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Cape Investment Advisory's 13F filing for Q2 2026, filed 23 Jul 2026.